Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01086761
What this trial is testing

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Allergan 32
Not applicableStudy completedNCT00845273
What this trial is testing

Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 3,538
Not applicableUnknownNCT02379169
What this trial is testing

Effects of Sea Buckthorn Oil and Lutein on Eye Health

Who this might be right for
Risk Factors for Age Related Macular Degeneration
Turku University Hospital 90
Testing effectiveness (Phase 2)Study completedNCT02140151
What this trial is testing

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Southern California Desert Retina Consultants, MC 108
Testing effectiveness (Phase 2)Study completedNCT02613572
What this trial is testing

Alpha Lipoic Acid in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
University of Pennsylvania 68
Not applicableUnknownNCT06465212
What this trial is testing

Personalized Shared Eye-care Identification of Age-related Macular Degeneration Using Artificial Intelligence and Telemedicine by Matching Optometrist Office-based Sites With Clinical Supervision

Who this might be right for
Age-Related Macular Degeneration
Medical University of Vienna 5,000
Large-scale testing (Phase 3)Study completedNCT05989126
What this trial is testing

Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-Related Macular Degeneration (nAMD)
Regeneron Pharmaceuticals 35
Large-scale testing (Phase 3)Ended earlyNCT00499590
What this trial is testing

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

Who this might be right for
Macular Degeneration
OPKO Health, Inc. 338
Not applicableUnknownNCT04005443
What this trial is testing

Molecular Imaging Exploration of Ocular Angiogenic Activity and Evaluation of Its Interest in the Therapeutic Follow-up of Patients With AMD (Age-related Macular Degeneration)

Who this might be right for
Age Related Macular Degeneration
Assistance Publique Hopitaux De Marseille 20
Not applicableNot Yet RecruitingNCT07554690
What this trial is testing

Photobiomodulation Laser for Reticular Pseudodrusen in Age-Related Macular Degeneration

Who this might be right for
AMD - Age-Related Macular Degeneration
Fondazione G.B. Bietti, IRCCS 67
Not applicableStudy completedNCT02337647
What this trial is testing

Evaluation of the Distortion Correction Data Collection (DCDC) App Software

Who this might be right for
Age-related Macular Degeneration
University of Nebraska 5
Post-approval studies (Phase 4)Study completedNCT01870440
What this trial is testing

TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema

Who this might be right for
Macular EdemaUveitis
Northern California Retina Vitreous Associates 10
Early research (Phase 1)Looking for participantsNCT07330674
What this trial is testing

ABF-101 in Single- and Multiple-Ascending Doses

Who this might be right for
Age Related Macular Degeneration (ARMD)AMD - Age-Related Macular Degeneration
Aptabio Therapeutics, Inc. 68
Not applicableUnknownNCT06355830
What this trial is testing

Intermediate Age-related Macular Degeneration - Multimodal Analysis and Longitudinal Study

Who this might be right for
Age-Related Macular Degeneration
Universidade Nova de Lisboa 150
Post-approval studies (Phase 4)UnknownNCT02806752
What this trial is testing

Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy

Who this might be right for
Wet Macular Degeneration
Aier School of Ophthalmology, Central South University 120
Large-scale testing (Phase 3)UnknownNCT00157976
What this trial is testing

Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Miravant Pharmaceuticals 660
Not applicableStudy completedNCT01527435
What this trial is testing

Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)

Who this might be right for
Exudative Age-Related Macular Degeneration
The Retina Center of St. Louis County, PC 200
Post-approval studies (Phase 4)Ended earlyNCT01939691
What this trial is testing

Macular Edema Nepafenac vs. Difluprednate Uveitis Trial

Who this might be right for
UveitisMacular Edema
University of California, San Francisco 9
Not applicableUnknownNCT04620876
What this trial is testing

Bimodal and Coaxial High Resolution Ophtalmic Imaging

Who this might be right for
Retinitis PigmentosaMaculopathy, Age RelatedMacular Dystrophy+8 more
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 1,200
Testing effectiveness (Phase 2)Study completedNCT04465955
What this trial is testing

NGM621 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy
NGM Biopharmaceuticals, Inc 320
Next Page